FR05C0047I2 - - Google Patents

Info

Publication number
FR05C0047I2
FR05C0047I2 FR05C0047C FR05C0047C FR05C0047I2 FR 05C0047 I2 FR05C0047 I2 FR 05C0047I2 FR 05C0047 C FR05C0047 C FR 05C0047C FR 05C0047 C FR05C0047 C FR 05C0047C FR 05C0047 I2 FR05C0047 I2 FR 05C0047I2
Authority
FR
France
Prior art keywords
ones
pyran
retrovirus
hydroxy
benzopyran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR05C0047C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of FR05C0047I1 publication Critical patent/FR05C0047I1/fr
Application granted granted Critical
Publication of FR05C0047I2 publication Critical patent/FR05C0047I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
FR05C0047C 1994-05-06 2005-12-22 Active FR05C0047I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23881794A 1994-05-06 1994-05-06
US34936194A 1994-12-02 1994-12-02
PCT/US1995/005219 WO1995030670A2 (fr) 1994-05-06 1995-05-04 Composes de pyranone utiles pour traiter des infections a retrovirus

Publications (2)

Publication Number Publication Date
FR05C0047I1 FR05C0047I1 (fr) 2006-03-10
FR05C0047I2 true FR05C0047I2 (fr) 2007-10-19

Family

ID=26931995

Family Applications (1)

Application Number Title Priority Date Filing Date
FR05C0047C Active FR05C0047I2 (fr) 1994-05-06 2005-12-22

Country Status (33)

Country Link
US (2) US5852195A (fr)
EP (1) EP0758327B1 (fr)
JP (1) JP3883206B2 (fr)
KR (1) KR100445929B1 (fr)
CN (2) CN1154642C (fr)
AT (1) ATE236894T1 (fr)
AU (2) AU701965B2 (fr)
BR (1) BR9507615A (fr)
CA (2) CA2187523C (fr)
CO (1) CO4810313A1 (fr)
CZ (1) CZ296515B6 (fr)
DE (2) DE122006000014I2 (fr)
DK (1) DK0758327T3 (fr)
ES (1) ES2192201T3 (fr)
FI (1) FI117387B (fr)
FR (1) FR05C0047I2 (fr)
HK (2) HK1066796A1 (fr)
HU (1) HU228057B1 (fr)
IL (3) IL129871A (fr)
LU (1) LU91220I2 (fr)
MX (1) MX9605391A (fr)
MY (2) MY149862A (fr)
NL (1) NL300216I2 (fr)
NO (2) NO315799B1 (fr)
NZ (1) NZ285510A (fr)
PE (1) PE23196A1 (fr)
PL (1) PL190540B1 (fr)
PT (1) PT758327E (fr)
RU (1) RU2139284C1 (fr)
SI (1) SI0758327T1 (fr)
SK (1) SK284407B6 (fr)
TW (1) TW504507B (fr)
WO (1) WO1995030670A2 (fr)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
US5914332A (en) 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
EP0909184B1 (fr) * 1996-07-03 2003-09-17 PHARMACIA & UPJOHN COMPANY Distribution ciblee de medicaments a l'aide de derives de sulfonamides
US5834506A (en) * 1996-11-01 1998-11-10 Warner-Lambert Company Dihydropyrones with improved antiviral activity
US6232333B1 (en) 1996-11-21 2001-05-15 Abbott Laboratories Pharmaceutical composition
KR100509130B1 (ko) * 1997-07-29 2005-08-18 파마시아 앤드 업존 캄파니 엘엘씨 친지성 화합물의 자가유화 제제
BR9810729B1 (pt) * 1997-07-29 2010-07-13 composição farmacêutica para compostos lipofìlicos ácidos disposta como uma formulação auto-emulsificante.
JP2002511099A (ja) * 1997-07-29 2002-04-09 ファルマシア・アンド・アップジョン・カンパニー 親油性化合物用の自己乳化性処方
PL193240B1 (pl) * 1997-09-11 2007-01-31 Upjohn Co Sposób wytwarzania hydroksylaktonu i związki pośrednie stosowane w tym sposobie
ES2185582T3 (es) * 1999-03-18 2003-05-01 Upjohn Co Procedimiento mejorado de hidrogenacion asimetrica.
US6956048B2 (en) * 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
CA2395987C (fr) 2000-01-19 2009-12-22 Abbott Laboratories Formulations pharmaceutiques ameliorees
DE10108470A1 (de) * 2001-02-22 2002-09-05 Boehringer Ingelheim Pharma Verfahren zur Herstellung optisch aktiver Dihydropyrone
US6500963B2 (en) 2001-02-22 2002-12-31 Boehringer Ingelheim Pharma Kg Process for preparing optically active dihydropyrones
BR0307944A (pt) * 2002-02-25 2005-02-01 Kudos Pharm Ltd Piranonas úteis como inibidores de atm
DE60307804T2 (de) * 2002-04-01 2007-01-18 Pfizer Inc. Pyranon- und pyrandioninhibitoren der rna-abhängigen rna-polymerase des hepatitis-c-virus
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8841326B2 (en) 2004-02-12 2014-09-23 Stc.Unm Therapeutic curcumin derivatives
IL161586A (en) * 2004-04-22 2015-02-26 Rafael Advanced Defense Sys Irreplaceable energetic material and reactive shielding that uses it
CA2583187A1 (fr) * 2004-11-08 2006-05-18 Boehringer Ingelheim International Gmbh Methode de traitement d'infection vih par coadministration de tipranavir et etravirine
WO2006055455A1 (fr) * 2004-11-16 2006-05-26 Boehringer Ingelheim International, Gmbh Procede pour le traitement d'une infection au vih par l'administration combinee de tipranavir et de darunavir
EP1814548A1 (fr) * 2004-11-19 2007-08-08 Boehringer Ingelheim International Gmbh Procede visant a traiter l'infection a vih par l'administration combinee du tipranavir et du reverset
US20060122220A1 (en) * 2004-11-19 2006-06-08 Boehringer Ingelheim International Gmbh Method for treating HIV infection through co-administration of tipranavir and UK-427,857
US20060142344A1 (en) * 2004-12-01 2006-06-29 Boehringer Ingelheim International Gmbh Method for treating HIV infection through co-administration of tipranavir and GW695634
CA2585663A1 (fr) * 2004-12-01 2006-06-08 Boehringer Ingelheim International Gmbh Procede de traitement d'une infection par le vih par co-administration de tipranavir et de sch-417690
EP1819333A1 (fr) * 2004-12-01 2007-08-22 Boehringer Ingelheim International Gmbh Methode de traitement de l'infection a vih par co-administration de tipranavir et de gw873140
WO2008112289A2 (fr) 2007-03-12 2008-09-18 Nektar Therapeutics Conjugués d'oligomère-inhibiteur de protéase
US20090062346A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched tipranavir
WO2009042093A1 (fr) * 2007-09-25 2009-04-02 Merck & Co., Inc. Inhibiteurs de la protéase du vih
EP2262498A2 (fr) * 2008-03-10 2010-12-22 Vertex Pharmceuticals Incorporated Pyrimidines et pyridines utiles comme inhibiteurs des protéines kinases
US9095620B2 (en) 2008-03-12 2015-08-04 Nektar Therapeutics Reagents
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
EA019295B1 (ru) 2008-12-23 2014-02-28 Джилид Фармассет, Ллс. Соединения пуриновых нуклеозидов и способ их получения
AU2009329867B2 (en) 2008-12-23 2015-01-29 Gilead Pharmasset Llc Nucleoside phosphoramidates
NZ617066A (en) 2008-12-23 2015-02-27 Gilead Pharmasset Llc Nucleoside analogs
CA2762582A1 (fr) 2009-05-27 2010-12-02 Merck Sharp & Dohme Corp. Inhibiteurs de la protease du vih
WO2010144869A2 (fr) 2009-06-12 2010-12-16 Nektar Therapeutics Inhibiteurs de protéase
GEP20156325B (en) 2009-06-17 2015-07-10 Vertex Pharma Inhibitors of influenza viruses replication
KR101466245B1 (ko) * 2010-01-15 2014-12-01 한미사이언스 주식회사 테트라졸 메탄설폰산 염의 제조방법 및 이에 사용되는 신규 화합물
AU2011235044A1 (en) 2010-03-31 2012-11-22 Gilead Pharmasset Llc Stereoselective synthesis of phosphorus containing actives
WO2012033815A1 (fr) * 2010-09-09 2012-03-15 Rutgers, The State University Of New Jersey Agents anti-bactériens à base d'arylpropionyl-alpha-pyrone
WO2012033846A1 (fr) 2010-09-09 2012-03-15 Rutgers, The State University Of New Jersey Agents antibactériens à base d'arylpropionyl-tricétone
WO2012037508A2 (fr) 2010-09-17 2012-03-22 Rutgers, The State University Of New Jersey Agents antibactériens : dérivés de myxopyronine de puissance élevée
US9079834B2 (en) 2010-10-28 2015-07-14 Merck Canada Inc. HIV protease inhibitors
WO2012083117A1 (fr) 2010-12-16 2012-06-21 Vertex Pharmaceuticals Incorporated Inhibiteurs de la réplication des virus de la grippe
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
EP2771332B1 (fr) 2011-10-26 2016-06-29 Merck Canada Inc. Dérivés sulfonamides de thiophen et thiazol en tant qu'inhibiteurs de la protease du HIV pour le traitement du SIDA
US9517994B2 (en) 2012-01-05 2016-12-13 Rutgers, The State University Of New Jersey Antibacterial agents: phloroglucinol derivatives
RU2015113091A (ru) * 2012-09-11 2016-11-10 Мерк Шарп И Доум Корп. Ингибиторы протеазы вич
US9227990B2 (en) 2012-10-29 2016-01-05 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
WO2015013835A1 (fr) 2013-07-31 2015-02-05 Merck Sharp & Dohme Corp. Dérivés de pipérazine utilisés en tant qu'inhibiteurs de la protéase du vih
JP6618901B2 (ja) 2013-11-13 2019-12-11 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ インフルエンザウイルスの複製の阻害剤を調製する方法
PL3068776T3 (pl) 2013-11-13 2019-10-31 Vertex Pharma Inhibitory replikacji wirusów grypy
US9737545B2 (en) 2013-12-19 2017-08-22 Merck Sharp & Dohme Corp. HIV protease inhibitors
WO2015095276A1 (fr) 2013-12-19 2015-06-25 Merck Sharp & Dohme Corp. Inhibiteurs de la protéase du vih
WO2015134366A1 (fr) 2014-03-06 2015-09-11 Merck Sharp & Dohme Corp. Inhibiteurs de la protéase du vih
WO2015138220A1 (fr) 2014-03-10 2015-09-17 Merck Sharp & Dohme Corp. Dérivés de pipérazine utilisés en tant qu'inhibiteurs de la protéase du vih
US9738664B2 (en) 2014-10-29 2017-08-22 Wisconsin Alumni Research Foundation Boronic acid inhibitors of HIV protease
EP3294735B8 (fr) 2015-05-13 2022-01-05 Vertex Pharmaceuticals Incorporated Inhibiteurs de la réplication des virus de la grippe
EP3294717B1 (fr) 2015-05-13 2020-07-29 Vertex Pharmaceuticals Inc. Procédés de préparation d'inhibiteurs de réplication des virus de la grippe
WO2017100645A2 (fr) 2015-12-10 2017-06-15 Rutgers, The State University Of New Jersey Inhibiteurs d'arn polymérase bactérienne : aryl propanoyle, aryl propénoyle et aryl cyclopropane carboxyl phloroglucinols
WO2017156458A1 (fr) * 2016-03-11 2017-09-14 University Of South Florida Inhibiteurs de bêta-lactamases, formulations et utilisations correspondantes
US20210246125A1 (en) * 2016-12-04 2021-08-12 712 North, Inc. Pyranone compounds useful to modulate oma1 protease
WO2019160873A1 (fr) 2018-02-13 2019-08-22 Rutgers, The State University Of New Jersey Agents antibactériens : pyronines o-alkyl-deutérés
WO2019173507A1 (fr) 2018-03-06 2019-09-12 Rutgers, The State University Of New Jersey Agents antibactériens : phloroglucinols arylalkylcarboxamido
CN110551090B (zh) * 2019-10-21 2021-06-18 扬州工业职业技术学院 一种超声波提取中药狗脊中抗肿瘤活性成分的方法
WO2021209563A1 (fr) 2020-04-16 2021-10-21 Som Innovation Biotech, S.A. Composés destinés à être utilisés dans le traitement d'infections virales par un coronavirus associé au syndrome respiratoire

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB193507A (en) 1921-11-25 1923-02-26 English Electric Co Ltd Improvements in and connected with hydraulic impulse turbines
NL80964C (fr) * 1952-03-08
NL83407C (fr) * 1952-05-16
US2723277A (en) * 1952-08-26 1955-11-08 Hoffmann La Roche Malonic acid derivatives and process for the manufacture thereof
US2872457A (en) * 1956-04-19 1959-02-03 Wisconsin Alumni Res Found Process for the preparation of 4-hydroxycoumarin derivatives
GB836740A (en) * 1956-04-25 1960-06-09 Bayer Ag Coumarin derivatives and their production
FR1276654A (fr) * 1958-10-01 1961-11-24 Nouveaux dérivés de l'hydroxy-4-alpha-2-pyrone
FR1463767A (fr) * 1963-04-03 1966-07-22 Clin Byla Ets Dérivés de la coumarine et leur préparation
BE674997A (fr) * 1965-01-13 1966-07-12
FR1559595A (fr) * 1966-12-13 1969-03-14
US3489774A (en) * 1967-04-24 1970-01-13 Dow Chemical Co 3-(beta-aryl-beta-(arylthio) (or arylseleno) propionyl)-coumarin products
US3493586A (en) * 1969-01-23 1970-02-03 Dow Chemical Co 3-(beta-aryl-beta-(arylthio) (or arylseleno)-propionyl)pyrone products
JPS4823942B1 (fr) * 1969-02-14 1973-07-17
US3764693A (en) * 1969-11-21 1973-10-09 Lipha A rodenticidal compositions containing 4-hydroxy coumarins
US3835161A (en) * 1972-10-24 1974-09-10 Realisations Scient S E Res C 3-substituted-4-hydroxy-coumarins
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
IL60751A (en) * 1979-08-17 1985-04-30 Merck & Co Inc 6-(2'-((substituted phenyl)ethyl and-ethenyl)-4-hydroxy-tetrahydro-2h-pyran-2-one derivatives,their preparation and pharmaceutical compositions containing them
CA1171424A (fr) * 1981-06-17 1984-07-24 Alvin K. Willard ( )-(4r, 6s) - (e)-6-[2-(4'fluoro-3,3', 5-trimethyl- [1,1'-biphenyle]-2-yl)ethenyle]-3,4,5,6- tetrahydro-4-hydroxy-2h-pyran-2-one
JPS634652A (ja) * 1986-06-25 1988-01-09 Hitachi Ltd 半導体装置
AU1044088A (en) 1986-12-17 1988-07-15 Nippon Soda Co., Ltd. Heterocyclic compounds having triketo skeleton
US4900754A (en) * 1987-12-21 1990-02-13 Rorer Pharmaceutical Corp. HMG-COA reductase inhibitors
JPH03503635A (ja) * 1988-03-01 1991-08-15 ジ・アップジョン・カンパニー ヒトにおいて逆転写酵素を抑制するクマリン類
DE3929913A1 (de) * 1989-09-08 1991-04-04 Hoechst Ag 4-hydroxytetrahydropyran-2-one sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate sowie vorprodukte
EP0494231A4 (en) * 1989-09-26 1992-09-16 The Regents Of The University Of California 6-amino-1,2-benzopyrones useful for treatment of viral diseases
JPH05501879A (ja) * 1989-10-27 1993-04-08 ジ・アップジョン・カンパニー Ｈｉｖおよび他のレトロウイルスを処理する方法およびそれに有用な化合物
JPH03227923A (ja) 1990-01-30 1991-10-08 Sawai Seiyaku Kk ひと免疫不全ウイルス疾患処置剤
SE9000624D0 (sv) * 1990-02-22 1990-02-22 Pharmacia Ab New use
CA2035972C (fr) * 1990-02-23 2006-07-11 Martin Karpf Procede de preparation d'oxetanones
AU8612491A (en) * 1990-09-07 1992-03-30 Schering Corporation Antiviral compounds
CA2091172C (fr) * 1990-09-07 1997-05-20 Adriano Afonso Composes antiviraux et composes antihypertensifs
AU8448491A (en) * 1990-09-07 1992-03-30 Schering Corporation Antiviral compounds and antihypertensive compounds
US5484951A (en) * 1990-10-19 1996-01-16 Octamer, Incorporated 5-iodo-6-amino-6-nitroso-1,2-benzopyrones useful as cytostatic and antiviral agents
JPH06506463A (ja) * 1991-04-04 1994-07-21 ジ・アップジョン・カンパニー Ｈｉｖおよび他のレトロウイルスの治療に有用な化合物
DE69232568T2 (de) * 1991-10-11 2002-12-19 Bristol Myers Squibb Pharma Co Cyclische Harnstoffe und Analoga verwendbar als retrovirale Proteasehemmer
WO1993007868A1 (fr) * 1991-10-22 1993-04-29 Octamer, Inc. Composes aromatiques nitreux liant l'adenosine-diphosphoribose polymerase efficaces en tant qu'agents antitumoraux et anti-retrovirus
DE4308451A1 (de) * 1992-09-10 1994-04-14 Bayer Ag 3-Aryl-pyron-Derivate
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
IL108459A0 (en) * 1993-02-05 1994-04-12 Opjohn Company 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections

Also Published As

Publication number Publication date
LU91220I2 (fr) 2006-04-10
CN1150424A (zh) 1997-05-21
IL113567A (en) 2003-05-29
AU701965B2 (en) 1999-02-11
HK1066796A1 (en) 2005-04-01
HU9603074D0 (en) 1997-01-28
NL300216I2 (nl) 2006-06-01
MY127701A (en) 2006-12-29
CZ296515B6 (cs) 2006-04-12
SK284407B6 (sk) 2005-03-04
FI964441A0 (fi) 1996-11-05
PT758327E (pt) 2003-08-29
JPH09512821A (ja) 1997-12-22
DE69530294D1 (de) 2003-05-15
NO964676D0 (no) 1996-11-05
CN1539825A (zh) 2004-10-27
HK1084667A1 (en) 2006-08-04
CN1329378C (zh) 2007-08-01
CA2560489A1 (fr) 1995-11-16
NO964676L (no) 1997-01-06
CA2187523A1 (fr) 1995-11-16
RU2139284C1 (ru) 1999-10-10
IL129871A0 (en) 2000-02-29
BR9507615A (pt) 1997-09-09
CA2187523C (fr) 2006-11-21
TW504507B (en) 2002-10-01
PE23196A1 (es) 1996-06-07
DE122006000014I1 (de) 2006-11-16
AU2368699A (en) 1999-06-03
EP0758327B1 (fr) 2003-04-09
CO4810313A1 (es) 1999-06-30
PL190540B1 (pl) 2005-12-30
CZ317296A3 (en) 1997-04-16
AU2462695A (en) 1995-11-29
ES2192201T3 (es) 2003-10-01
SK138496A3 (en) 1997-06-04
PL317061A1 (en) 1997-03-03
FI117387B (fi) 2006-09-29
DE122006000014I2 (de) 2007-03-29
NL300216I1 (nl) 2006-04-03
US5852195A (en) 1998-12-22
US6169181B1 (en) 2001-01-02
WO1995030670A3 (fr) 1996-04-25
AU718117B2 (en) 2000-04-06
MY149862A (en) 2013-10-31
KR970702858A (ko) 1997-06-10
HUT77601A (hu) 1998-06-29
NO2006003I2 (no) 2008-10-20
NZ285510A (en) 1998-03-25
EP0758327A1 (fr) 1997-02-19
HU228057B1 (en) 2012-09-28
CN1154642C (zh) 2004-06-23
KR100445929B1 (ko) 2005-09-30
FI964441A (fi) 1996-11-05
JP3883206B2 (ja) 2007-02-21
IL129871A (en) 2003-11-23
NO315799B1 (no) 2003-10-27
NO2006003I1 (no) 2006-03-13
DK0758327T3 (da) 2003-07-28
MX9605391A (es) 1997-12-31
DE69530294T2 (de) 2003-12-24
ATE236894T1 (de) 2003-04-15
WO1995030670A2 (fr) 1995-11-16
CA2560489C (fr) 2010-01-12
FR05C0047I1 (fr) 2006-03-10
SI0758327T1 (en) 2003-08-31

Similar Documents

Publication Publication Date Title
FR05C0047I2 (fr)
MY119031A (en) Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
NO953070D0 (no) 4-hydroksy-benzopyran-2-oner og 4-hydroksysykloalkyl[BÅpyran-2-oner anvendbare for behandling av retrovirusinfeksjoner
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
TR199700470A2 (xx) Sildenafilin haz�rlanmas� i�in proses.
AU4188700A (en) Pseudomycin natural products